Login to your account
Don’t have an account?
Create a Free AccountProcedures - Advanced imaging
Endoscopic findings of checkpoint inhibitor–induced ileitis with use of the latest advanced endoscopic optical diagnosis: near-focus narrow-band imaging
Cancer immunotherapy with the use of checkpoint inhibitors, ipilimumab (anti-cytotoxic T lymphocyte antigen) or nivolumab, pembrolizumab, and atezolizumab (anti-programmed death-1) may induce colitis, an increasingly recognized immune-mediated adverse event (IrAE). The spectrum of endoscopic findings at colonoscopy has not been defined comprehensively; Crohn’s-like and ulcerative colitis–like changes have been described.1,2 Colitis is most commonly described, although ileoscopy is not always conducted.
Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.
